{"id": "1350457786275155968", "creation": 1610809201.0, "user_id": "8457092", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 4, "reply_count": 1, "like_count": 19, "quote_count": 0}}, "text": "How can #lifesciences companies build capabilities to store and administer #COVID19 #vaccine, and deal with any unprecedented logistical challenges? Deloitte's latest report explores.\n\nhttps://t.co/LFiyXEI4uE https://t.co/cf4LuVjveX", "first_save": 1634559108.199414, "hashtags": ["#LIFESCIENCES", "#COVID19", "#VACCINE"]}